Pseudomonas aeruginosa DSM 1299 is a mesophilic human pathogen that was isolated from sputum.
mesophilic human pathogen
SI-ID 47348
| @ref 20215 |
Last LPSN update
2025-12-16 09:49:55 |
| Domain Pseudomonadati |
| Phylum Pseudomonadota |
| Class Gammaproteobacteria |
| Order Pseudomonadales |
| Family Pseudomonadaceae |
| Genus Pseudomonas |
| Species Pseudomonas aeruginosa |
| Full scientific name Pseudomonas aeruginosa (Schroeter 1872) Migula 1900 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Name | Growth | Medium link | Composition | |
|---|---|---|---|---|---|
| 630 | NUTRIENT AGAR (DSMZ Medium 1) | Medium recipe at MediaDive  | Name: NUTRIENT AGAR (DSMZ Medium 1) Composition: Agar 15.0 g/l Peptone 5.0 g/l Meat extract 3.0 g/l Distilled water |
| @ref | Growth | Type | Temperature (°C) | Range | |
|---|---|---|---|---|---|
| 630 | positive | growth | 37 | mesophilic |
| @ref | Chebi-ID | Metabolite | Utilization activity | Kind of utilization tested | |
|---|---|---|---|---|---|
| 68369 | 17128 ChEBI | adipate | + | assimilation | from API 20NE |
| 68369 | 29016 ChEBI | arginine | + | hydrolysis | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | + | assimilation | from API 20NE |
| 68369 | 17634 ChEBI | D-glucose | - | fermentation | from API 20NE |
| 68369 | 16899 ChEBI | D-mannitol | - | assimilation | from API 20NE |
| 68369 | 16024 ChEBI | D-mannose | - | assimilation | from API 20NE |
| 68369 | 27689 ChEBI | decanoate | + | assimilation | from API 20NE |
| 68369 | 4853 ChEBI | esculin | - | hydrolysis | from API 20NE |
| 68369 | 5291 ChEBI | gelatin | - | hydrolysis | from API 20NE |
| 68369 | 24265 ChEBI | gluconate | - | assimilation | from API 20NE |
| 68369 | 30849 ChEBI | L-arabinose | - | assimilation | from API 20NE |
| 68369 | 25115 ChEBI | malate | + | assimilation | from API 20NE |
| 68369 | 17306 ChEBI | maltose | - | assimilation | from API 20NE |
| 68369 | 59640 ChEBI | N-acetylglucosamine | + | assimilation | from API 20NE |
| 68369 | 17632 ChEBI | nitrate | + | reduction | from API 20NE |
| 68369 | 27897 ChEBI | tryptophan | - | energy source | from API 20NE |
| 68369 | 16199 ChEBI | urea | + | hydrolysis | from API 20NE |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Pathogenicity | Bactericidal ZnO glass-filled thermoplastic polyurethane and polydimethyl siloxane composites to inhibit biofilm-associated infections. | Cabal B, Sevillano D, Fernandez-Garcia E, Alou L, Suarez M, Gonzalez N, Moya JS, Torrecillas R. | Sci Rep | 10.1038/s41598-019-39324-w | 2019 | |
| Effect of the Medium Composition on the Zn2+ Lixiviation and the Antifouling Properties of a Glass with a High ZnO Content. | Esteban-Tejeda L, Palomares FJ, Cabal B, Lopez-Piriz R, Fernandez A, Sevillano D, Alou L, Torrecillas R, Moya JS. | Materials (Basel) | 10.3390/ma10020167 | 2017 | | |
| Pathogenicity | A new biocompatible and antibacterial phosphate free glass-ceramic for medical applications. | Cabal B, Alou L, Cafini F, Couceiro R, Sevillano D, Esteban-Tejeda L, Guitian F, Torrecillas R, Moya JS. | Sci Rep | 10.1038/srep05440 | 2014 | |
| Variations in properties of L-forms of Pseudomonas aeruginosa. | Bertolani R, Elberg SS, Ralston D. | Infect Immun | 10.1128/iai.11.1.180-192.1975 | 1975 | | |
| Pathogenicity | Procedures for the assay of carbenicillin in body fluids. | Burnett J, Sutherland R. | Appl Microbiol | 10.1128/am.19.2.264-267.1970 | 1970 | |
| Pathogenicity | Antimicrobial activity of betaine esters, quaternary ammonium amphiphiles which spontaneously hydrolyze into nontoxic components. | Lindstedt M, Allenmark S, Thompson RA, Edebo L. | Antimicrob Agents Chemother | 10.1128/aac.34.10.1949 | 1990 | |
| Metabolism | Piperacillin-tazobactam penetration into human pancreatic juice. | Bertazzoni Minelli E, Benini A, Franco L, Bassi C, Pederzoli P. | Antimicrob Agents Chemother | 10.1128/aac.00509-08 | 2008 | |
| Pathogenicity | In vitro antibacterial properties of BRL 36650, a novel 6 alpha-substituted penicillin. | Basker MJ, Edmondson RA, Knott SJ, Ponsford RJ, Slocombe B, White SJ. | Antimicrob Agents Chemother | 10.1128/aac.26.5.734 | 1984 | |
| Pathogenicity | BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans. | Slocombe B, Basker MJ, Bentley PH, Clayton JP, Cole M, Comber KR, Dixon RA, Edmondson RA, Jackson D, Merrikin DJ, Sutherland R. | Antimicrob Agents Chemother | 10.1128/aac.20.1.38 | 1981 | |
| Pathogenicity | Comparative sensitivity and resistance of some strains of Pseudomonas aeruginosa and Pseudomonas stutzeri to antibacterial agents. | Russell AD, Mills AP. | J Clin Pathol | 10.1136/jcp.27.6.463 | 1974 | |
| BRL-36650: in vitro studies and assessment of serum bactericidal activity after single-dose administration in volunteers. | Pascual-Lopez A, Van der Auwera P, Lieppe S, Klastersky J. | Antimicrob Agents Chemother | 10.1128/aac.29.5.757 | 1986 | | |
| Phylogeny | Kit systems for identifying gram negative aerobic bacilli: report of the Welsh Standing Specialist Advisory Working Group in Microbiology. | Bennett CH, Joynson DH. | J Clin Pathol | 10.1136/jcp.39.6.666 | 1986 | |
| Pathogenicity | Comparative bactericidal effects of azlocillin and ticarcillin against Pseudomonas aeruginosa. | White AR, Comber KR, Sutherland R. | Antimicrob Agents Chemother | 10.1128/aac.18.1.182 | 1980 | |
| Cultivation | Value of the K+ salt of carageenan as an agar substitute in routine bacteriological media. | Lines AD. | Appl Environ Microbiol | 10.1128/aem.34.6.637-639.1977 | 1977 | |
| Pathogenicity | Comparison of serum bactericidal activity among three antimicrobial combinations. | Murillo J, Standiford HC, Schimpff SC, Tatem BA. | Antimicrob Agents Chemother | 10.1128/aac.13.6.992 | 1978 | |
| Enzymology | Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin. | Wise R, Logan M, Cooper M, Andrews JM. | Antimicrob Agents Chemother | 10.1128/aac.35.6.1081 | 1991 | |
| Monitoring aminoglycoside use in patients with severely impaired renal function. | Noone P, Beale DF, Pollock SS, Perera MR, Amirak ID, Fernando ON, Moorhead JF. | Br Med J | 10.1136/bmj.2.6135.470 | 1978 | | |
| Metabolism | Ticarcillin-clavulanic acid pharmacokinetics in preterm neonates with presumed sepsis. | Burstein AH, Wyble LE, Gal P, Diaz PR, Ransom JL, Carlos RQ, Forrest A. | Antimicrob Agents Chemother | 10.1128/aac.38.9.2024 | 1994 | |
| Metabolism | Concentrations of ticarcillin and clavulanic acid in human bone after prophylactic administration of 5.2 g of timentin. | Adam D, Heilmann HD, Weismeier K. | Antimicrob Agents Chemother | 10.1128/aac.31.6.935 | 1987 | |
| Comparative in vitro activity and clinical pharmacology of ticarcillin and carbenicillin. | Neu HC, Garvey GJ. | Antimicrob Agents Chemother | 10.1128/aac.8.4.457 | 1975 | | |
| Pathogenicity | Comparison and evaluation of ticarcillin and carbenicillin using disk diffusion methods. | Parry MF, Neu HC. | Antimicrob Agents Chemother | 10.1128/aac.9.4.625 | 1976 | |
| Pathogenicity | Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo. | Boon RJ, Beale AS, Sutherland R. | Antimicrob Agents Chemother | 10.1128/aac.29.5.838 | 1986 | |
| Interactions of carbenicillin and ticarcillin with gentamicin. | Davies M, Morgan JR, Anand C. | Antimicrob Agents Chemother | 10.1128/aac.7.4.431 | 1975 | | |
| Enzymology | Pharmacokinetics and distribution of ticarcillin-clavulanic acid (Timentin) in experimental animals. | Woodnutt G, Kernutt I, Mizen L. | Antimicrob Agents Chemother | 10.1128/aac.31.11.1826 | 1987 | |
| Metabolism | Complementary use of aesculin hydrolysis and inositol fermentation in the characterisation of Klebsielleae. | Barr JG, Mahood RJ. | J Clin Pathol | 10.1136/jcp.30.1.45 | 1977 | |
| Enzymology | Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis. | Mizen L, Woodnutt G, Kernutt I, Catherall EJ. | Antimicrob Agents Chemother | 10.1128/aac.33.5.693 | 1989 | |
| Pathogenicity | [Discrepancy in the disk diffusion susceptibility test of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients after anaerobic preincubation and its potential clinical relevance]. | Cafini F, Garcia-Rey C, Bas P, Gomez-Lus ML, Sanchez I, Vazquez S, Prieto J | Rev Esp Quimioter | cafini | 2012 | |
| Pathogenicity | Human pharmacokinetics of temocillin (BRL 17421) side chain epimers. | Guest EA, Horton R, Mellows G, Slocombe B, Swaisland AJ, Tasker TC | J Antimicrob Chemother | 10.1093/jac/15.3.327 | 1985 | |
| Metabolism | Human pharmacokinetics and antimicrobial activities of the temocillin epimers. | Guest EA, Horton R, Mellows G, Slocombe B, Swaisland AJ, Tasker TC, White AR | Drugs | 10.2165/00003495-198500295-00032 | 1985 | |
| Enzymology | Beta-lactamases: determination of their isoelectric points. | Barthelemy M, Guionie M, Labia R | Antimicrob Agents Chemother | 10.1128/AAC.13.4.695 | 1978 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive12762.20251217.10
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License